Quetiapine
Product Images NDC 53002-1529

4 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 53002-1529). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530021529)

Label Image (Lbl530021529)
Quetiapine 50 mg tablets packaging label by RPK Pharmaceuticals, Inc. The label indicates a count of 30 tablets per container. It includes prescription information such as dosage instructions to take tablets as directed, patient name, and barcode. Additional labeling information includes warnings about drowsiness and alcohol use, and instructions to read the medication guide.*
FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 7) (Quetiapine Fig1)

Figure 1 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 7) (Quetiapine Fig1)
A line graph showing the proportion (%) of patients with relapse over time in weeks. Two treatment groups are compared: QTP + LIVAL and PLA + LIVAL, with the y-axis representing relapse percentage from 0 to 100% and the x-axis showing time up to 100 weeks. The graph depicts how relapse rates increase over time for both groups.*
FDA Label Image

Figure 2 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 8) (Quetiapine Fig2)

Figure 2 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 8) (Quetiapine Fig2)
A line graph showing the proportion of patients with relapse (%) over time in weeks for two groups: one treated with Quetiapine plus Li/Val (dashed line) and the other with placebo plus Li/Val (solid line). The graph depicts patient relapse increasing over time, with the placebo group showing a higher relapse rate compared to the Quetiapine group across the weeks.*
FDA Label Image

Chemstructure (Quetiapine Str)

Chemstructure (Quetiapine Str)
Chemical structure diagram of the active ingredient in Quetiapine marketed by RPK Pharmaceuticals, Inc. The image displays the molecular structure of quetiapine with its chemical components arranged graphically.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.